Rotavirus Infections: Clinical Trials

6 trials for Rotavirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Rotavirus Infections: new trials by email Literature Review of Rotavirus Infections trials Research Report on Rotavirus Infections

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity
Rotarix, dose 1, Rotarix, dose 2, Placebo (for Rotarix dose 2) - Rotavirus Infection, Vaccine Response Impaired
Phase 4CompletedUniversity of Vermont2202017-06-122020-08-04
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
Rotarix®,, Rotarix®, with other routine vaccines, RotaTeq®, - Intussusception, Rotavirus Infections
Phase 4CompletedChildren's Hospital Medical Center, Cincinnati1442015-11-012018-07-12
Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)
RotaTeq™ (V260), DTP-IPV - Rotavirus Disease
Phase 4CompletedMerck Sharp & Dohme LLC1922013-09-192018-11-14
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Rotarix®, RotaTeq® - Rotavirus Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)13842011-03-012014-10-28
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.
Rotarix TM - Infections, Rotavirus
Phase 4CompletedGlaxoSmithKline152010-11-112018-08-20
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants
Rotarix ™, Placebo - Infections, Rotavirus, Rotavirus Vaccines
Phase 4CompletedGlaxoSmithKline6842009-08-252020-01-18

Narrower conditions

Gastroenteritis (2)  ·  Intussusception (1)

Broader conditions

Infections (6)  ·  RNA Virus Infections (6)  ·  Reoviridae Infections (6)  ·  Virus Diseases (6)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (1)  ·  Intestinal Obstruction (1)

Interventions

RIX4414 vaccine (4)  ·  RotaTeq (3)  ·  Rotavirus Vaccines (2)  ·  DTP-IPV-Hib vaccine (1)

Sponsors

GlaxoSmithKline (2)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of Vermont (1)

Countries

United States (2)  ·  Bangladesh (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Benjamin Lee, M.D. (1)  ·  Karen Broder, MD (1)  ·  Mary A. Staat, MD, MPH (1)

Results publications

PMID 24079716, PMID 26823540, PMID 28140752, PMID 31607603

NIH funding

2015 (1)